| VRTX | Vertex Pharmaceuticals Inc | 10.37% |
| REGN | Regeneron Pharmaceuticals Inc | 8.02% |
| ALNY | Alnylam Pharmaceuticals Inc | 7.68% |
| ARGX | argenx SE ADR | 5.89% |
| NBIX | Neurocrine Biosciences Inc | 4.95% |
| TEVA | Teva Pharmaceutical Industries Ltd ADR | 4.40% |
| LLY | Eli Lilly and Co | 4.00% |
| CRNX | Crinetics Pharmaceuticals Inc | 3.69% |
| IONS | Ionis Pharmaceuticals Inc | 3.53% |
| SYK | Stryker Corp | 3.40% |
The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.
Tema Neuroscience And Mental Health ETF · Issued by Tema
No recent news for MNTL. The ingest cron pulls every 15 minutes during market hours.